Andersen Eric's Form 4 filing
Merrimack Pharmaceuticals Inc (MACK) · filed Jan 3, 2023
- Accession no.
- 0000899243-23-000225
- Filed
- Jan 3, 2023, 4:16 PM ET
- Trade date
- Dec 29-30, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.77M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Andersen EricCIK 0001517667 | Director, Other: See remarks |
| Western Standard Partners LPCIK 0001450414 | Other: See Remarks |
| Western Standard LLCCIK 0001517666 | Other: See Remarks |
| Western Standard Partners QP, L.P.CIK 0001544857 | Other: See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2022 | Common Stock | PPurchaseAcquired | +189,975 | $10.55 | +$2,004,293.24 | 1,190,195 | Indirect | |
| Dec 29, 2022 | Common Stock | PPurchaseAcquired | +28,661 | $10.55 | +$302,382.15 | 297,999 | Indirect | |
| Dec 30, 2022 | Common Stock | PPurchaseAcquired | +33,030 | $11.33 | +$374,319.08 | 1,223,225 | Indirect | |
| Dec 30, 2022 | Common Stock | PPurchaseAcquired | +8,270 | $11.33 | +$93,721.43 | 306,269 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.